DK1165615T3 - Monoklonale antistoffer mod humant protein Mcm3, proces til deres fremstilling af deres anvendelse - Google Patents

Monoklonale antistoffer mod humant protein Mcm3, proces til deres fremstilling af deres anvendelse

Info

Publication number
DK1165615T3
DK1165615T3 DK00920645T DK00920645T DK1165615T3 DK 1165615 T3 DK1165615 T3 DK 1165615T3 DK 00920645 T DK00920645 T DK 00920645T DK 00920645 T DK00920645 T DK 00920645T DK 1165615 T3 DK1165615 T3 DK 1165615T3
Authority
DK
Denmark
Prior art keywords
monoclonal antibodies
mcm3
preparation
immunobiochemical
prevention
Prior art date
Application number
DK00920645T
Other languages
Danish (da)
English (en)
Inventor
Johannes Gerdes
Thomas Scholzen
Elmar Endl
Claudia Wohlenberg
Bettina Baron-Luhr
Margrit Hahn
Patricia Prilla
Johanna Szuwinski
Rolf Knippers
Original Assignee
Dakocytomation Denmark As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dakocytomation Denmark As filed Critical Dakocytomation Denmark As
Application granted granted Critical
Publication of DK1165615T3 publication Critical patent/DK1165615T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/14—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK00920645T 1999-04-01 2000-03-31 Monoklonale antistoffer mod humant protein Mcm3, proces til deres fremstilling af deres anvendelse DK1165615T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19915057A DE19915057A1 (de) 1999-04-01 1999-04-01 Monoklonale Antikörper gegen das humane Mcm3 Protein, Verfahren zu ihrer Herstellung und ihre Verwendung
PCT/EP2000/002910 WO2000059943A2 (en) 1999-04-01 2000-03-31 MONOCLONAL ANTIBODIES AGAINST HUMAN PROTEIN Mcm3, PROCESS FOR THEIR PRODUCTION, AND THEIR USE

Publications (1)

Publication Number Publication Date
DK1165615T3 true DK1165615T3 (da) 2005-08-15

Family

ID=7903372

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00920645T DK1165615T3 (da) 1999-04-01 2000-03-31 Monoklonale antistoffer mod humant protein Mcm3, proces til deres fremstilling af deres anvendelse

Country Status (9)

Country Link
US (2) US6777194B1 (de)
EP (1) EP1165615B1 (de)
JP (1) JP4980516B2 (de)
AT (1) ATE296316T1 (de)
AU (1) AU4114800A (de)
DE (2) DE19915057A1 (de)
DK (1) DK1165615T3 (de)
ES (1) ES2239594T3 (de)
WO (1) WO2000059943A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2156370T3 (da) 2007-05-14 2012-01-23 Historx Inc Kompartmentadskillelse ved pixelkarakterisering under anvendelse af billeddata-clustering
JP5593221B2 (ja) 2007-06-15 2014-09-17 ヒストロックス，インコーポレイテッド． 顕微鏡機器を標準化するための方法およびシステム
CA2604317C (en) 2007-08-06 2017-02-28 Historx, Inc. Methods and system for validating sample images for quantitative immunoassays
CA2596204C (en) 2007-08-07 2019-02-26 Historx, Inc. Method and system for determining an optimal dilution of a reagent
US7978258B2 (en) * 2007-08-31 2011-07-12 Historx, Inc. Automatic exposure time selection for imaging tissue
GB0720113D0 (en) * 2007-10-15 2007-11-28 Cambridge Cancer Diagnostics L Diagnostic, prognostic and predictive testing for cancer
EP2335221B8 (de) 2008-09-16 2016-05-25 Novartis AG Reproduzierbare quantifizierung einer biomarkerexpression
ES2911415T3 (es) 2015-06-08 2022-05-19 Arquer Diagnostics Ltd Métodos y kits
EP3304082B1 (de) 2015-06-08 2020-05-13 Arquer Diagnostics Limited Methode zur analyse einer urinprobe

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281061A (en) * 1979-07-27 1981-07-28 Syva Company Double antibody for enhanced sensitivity in immunoassay
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (de) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimäre Rezeptoren durch Verbindung und Expression von DNS
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
DE3689123T2 (de) 1985-11-01 1994-03-03 Xoma Corp Modulare einheit von antikörpergenen, daraus hergestellte antikörper und verwendung.
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
ATE151110T1 (de) 1988-09-02 1997-04-15 Protein Eng Corp Herstellung und auswahl von rekombinantproteinen mit verschiedenen bindestellen
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5750373A (en) 1990-12-03 1998-05-12 Genentech, Inc. Enrichment method for variant proteins having altered binding properties, M13 phagemids, and growth hormone variants
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
WO1992020791A1 (en) 1990-07-10 1992-11-26 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
WO1992010147A1 (en) 1990-12-14 1992-06-25 Mondre Steven J Nicotine-containing dental floss
CA2105300C (en) 1991-03-01 2008-12-23 Robert C. Ladner Process for the development of binding mini-proteins
JP3672306B2 (ja) 1991-04-10 2005-07-20 ザ スクリップス リサーチ インスティテュート ファージミドを使用するヘテロ二量体受容体ライブラリー
DE4122599C2 (de) 1991-07-08 1993-11-11 Deutsches Krebsforsch Phagemid zum Screenen von Antikörpern
US5876438A (en) * 1993-08-02 1999-03-02 Houston Biotechnology Incorporated Polymeric device for the delivery of immunotoxins for the prevention of secondary cataract
US6316208B1 (en) * 1994-01-07 2001-11-13 Memorial Sloan-Kettering Cancer Center Methods for determining isolated p27 protein levels and uses thereof
US6156500A (en) * 1995-02-10 2000-12-05 Millennium Pharmaceuticals, Inc. Methods for the treatment and diagnosis of cardiovascular disease
US6303323B1 (en) 1997-10-21 2001-10-16 Cancer Research Campaign Technology Limited Detection of dysplastic or neoplastic cells using anti-MCM5 antibodies

Also Published As

Publication number Publication date
JP4980516B2 (ja) 2012-07-18
EP1165615B1 (de) 2005-05-25
DE19915057A1 (de) 2000-10-19
AU4114800A (en) 2000-10-23
ES2239594T3 (es) 2005-10-01
US6777194B1 (en) 2004-08-17
ATE296316T1 (de) 2005-06-15
DE60020353D1 (de) 2005-06-30
EP1165615A2 (de) 2002-01-02
WO2000059943A3 (en) 2001-03-22
US20040146513A1 (en) 2004-07-29
DE60020353T2 (de) 2006-01-26
WO2000059943A2 (en) 2000-10-12
JP2002541157A (ja) 2002-12-03

Similar Documents

Publication Publication Date Title
WO2021163064A3 (en) Antibodies and fusion proteins that bind to ccr8 and uses thereof
CY1115456T1 (el) Μεθοδος χορηγησης αντισωματων αντι-ιl-5
HUP9802212A2 (hu) Humán terápiában alkalmazható rekombináns anti-CD4-ellenanyagok
NZ594466A (en) Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) and methods for using anti-PTK7 antibodies
BR0309254A (pt) Uso de um anticorpo anti-ctla-4
UA95478C2 (ru) ГУМАНИЗИРОВАННОЕ АНТИТЕЛО, КОТОРОЕ СПЕЦИФИЧЕСКИ СВЯЗЫВАЕТ с-Kit
BR0110927A (pt) Anticorpo, ácido nucléico, vetor, célula, método de fabricar um anticorpo, composição farmacêutica, uso de um anticorpo ou de um ácido nucleico, e, método para o tratamento ou profilaxia do câncer
RU2012129735A (ru) Антитела к her3 и их применения
GEP20094829B (en) Fully human antibodies against human 4-1bb (cd137)
PE20071055A1 (es) Anticuerpos anti mn
WO2006087637A3 (en) Anti her2/neu antibody
NZ596409A (en) Anti macrophage migration inhibitory factor antibodies
WO2019060750A3 (en) A33 antibody compositions and methods of using the same in radioimmunotherapy
DK0853487T3 (da) Neutraliserende monoklonale antistoffer mod respiratorisk syncytial virus
WO2004094473A3 (en) Humanized antibodies to interferon alpha receptor-1 (ifnar-1)
DK1165615T3 (da) Monoklonale antistoffer mod humant protein Mcm3, proces til deres fremstilling af deres anvendelse
MX2021009975A (es) Anticuerpos de cd33 y métodos para usar los mismos para tratar el cáncer.
WO2022082073A3 (en) Compositions and methods for muc18 targeting
MX2022012628A (es) Anticuerpos anti-phf-tau y usos de estos.
ATE151078T1 (de) Verfahren und zwischenprodukte synthetischer antikörperderivate
MX2023011339A (es) Anticuerpos anti-tau y usos de estos.
RU2017145662A (ru) Моноклональные антитела и способы их применения
MX2021000783A (es) Anticuerpos humanizados contra psma.
EP0378418A3 (de) Proliferationsinhibitoren von Immunzellen
NZ593171A (en) Monoclonal antibody SC104 and derivative thereof specifically binding to a sialyltetraosyl carbohydrate as a potential anti-tumor therapeutic agent